HLA variation and disease

CA Dendrou, J Petersen, J Rossjohn… - Nature Reviews …, 2018 - nature.com
Fifty years since the first description of an association between HLA and human disease,
HLA molecules have proven to be central to physiology, protective immunity and …

The value of Autoimmune Syndrome Induced by Adjuvant (ASIA)-Shedding light on orphan diseases in autoimmunity

Y Segal, S Dahan, K Sharif, NL Bragazzi, A Watad… - Autoimmunity …, 2018 - Elsevier
Abstract Autoimmune Syndrome Induced by Adjuvant (ASIA) is a definition aimed to
describe the common etiological process at the root of five clinical entities sharing similar …

[HTML][HTML] Causality assessment of adverse events following immunization: the problem of multifactorial pathology

P Bellavite - F1000Research, 2020 - ncbi.nlm.nih.gov
Abstract The analysis of Adverse Events Following Immunization (AEFI) is important in a
balanced epidemiological evaluation of vaccines and in the issues related to vaccine injury …

Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival

P Hallberg, H Smedje, N Eriksson, H Kohnke… - …, 2019 - thelancet.com
Background The incidence of narcolepsy rose sharply after the swine influenza A (H1N1)
vaccination campaign with Pandemrix. Narcolepsy is an immune-related disorder with …

Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?

SM Buonocore, RG van der Most - Frontiers in Immunology, 2022 - frontiersin.org
In the wake of the A/California/7/2009 H1N1 influenza pandemic vaccination campaigns in
2009-2010, an increased incidence of the chronic sleep-wake disorder narcolepsy was …

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy

HM Ollila, E Sharon, L Lin, N Sinnott-Armstrong… - Nature …, 2023 - nature.com
Abstract Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk
factors include pandemic 2009 H1N1 influenza A infection and immunization with …

Prostaglandin D2 receptor DP1 antibodies predict vaccine-induced and spontaneous narcolepsy type 1: large-scale study of antibody profiling

H Sadam, A Pihlak, A Kivil, S Pihelgas, M Jaago… - …, 2018 - thelancet.com
Background Neuropathological findings support an autoimmune etiology as an underlying
factor for loss of orexin-producing neurons in spontaneous narcolepsy type 1 (narcolepsy …

Identifying and reducing risks of neurological complications associated with vaccination

L Handunnetthi, MN Ramasamy, L Turtle… - Nature Reviews …, 2024 - nature.com
Vaccines protect against many infectious diseases, including some that can directly or
indirectly cause nervous system damage. Serious neurological consequences of …

[HTML][HTML] Clinical update on central hypersomnias

L Pérez-Carbonell, G Leschziner - Journal of thoracic disease, 2018 - ncbi.nlm.nih.gov
The central hypersomnias encompass a range of conditions causing persisting or
intermittent excessive daytime sleepiness (EDS). These conditions therefore present not …

Decreased body mass index during treatment with sodium oxybate in narcolepsy type 1

MS Schinkelshoek, IM Smolders… - Journal of Sleep …, 2019 - Wiley Online Library
Narcolepsy type 1 is characterised by an increase in body weight after disease onset,
frequently leading to obesity. It was suggested that this weight gain may be counteracted by …